Description: <b>Capsaicin </b>is a chemical compound that gives chili peppers their spicy flavor and heat.<br>
<br>
Biological activity, capsaicin has been reported to exhibit a range of effects, including:<br>
Pain relief: 10-50 μM<br>
Anti-inflammatory activity: 20-50 μM<br>
Antioxidant activity: 10-100 μM<br>
Anti-cancer activity: 50-100 μM<br>
Cardiovascular health: 20-50 μM<br>
<br>
Approximate μM concentrations of capsaicin, the active compound in chili peppers, that can be achieved with different amounts of chili peppers:<br>
1 teaspoon of dried chili pepper flakes (5g):~10-50 μM of capsaicin<br>
1 tablespoon of dried chili pepper flakes (15g): ~30-150 μM of capsaicin<br>
1 cup of fresh chili peppers (100g): ~100-500 μM of capsaicin<br>
1 teaspoon of chili pepper extract (5g): ~100-500 μM of capsaicin<br>
1 tablespoon of chili pepper extract (15g): ~300-1500 μM of capsaicin<br>
<br>
Approximate μM concentrations of capsaicin in various foods that contain capsaicin:<br>
Jalapeño peppers: 1 pepper (20g): ~20-100 μM of capsaicin 2–8 mg/100g of fresh Jalapeño <br>
Serrano peppers: 1 pepper (10g): ~10-50 μM of capsaicin 5–15 mg/100g<br>
Cayenne peppers: 1 pepper (10g): ~50-200 μM of capsaicin<br>
Habanero peppers: 1 pepper (20g): ~100-500 μM of capsaicin 15–30 mg/100g<br>
Ghost peppers: 1 pepper (20g): ~200-1000 μM of capsaicin<br>
Hot sauce: 1 teaspoon (5g): ~10-50 μM of capsaicin<br>
Chili flakes: 1 teaspoon (5g): ~10-50 μM of capsaicin<br>
Spicy sauces and marinades: 1 tablespoon (15g): ~10-50 μM of capsaicin<br>
<br>
Cayenne Pepper Powder – Approximate capsaicin content: roughly 5–20 mg/g (15-30g human for 100uM?) <br>
<br>
-IC50 in Cancer Cell Lines: Approximately 50–300 µM (consume 150mg of capsaican not possible?)<br>
-IC50 in Normal Cell Lines: Generally higher—often 2–3 times greater <br>
<br>
Pathways:<br>
-disrupting mitochondrial membrane potential, leading to cytochrome c release and subsequent activation of caspases<br>
-Activation of TRPV1: resulting in increased intracellular calcium levels<br>
-capsaicin can lead to increased production of ROS within cancer cells<br>
-Inhibition of NF-κB<br>
-Inhibit PI3K/AKT/mTOR signaling<br>
-STAT3 Inhibition<br>
-Cell Cycle Arrest<br>
-reduce the expression of vascular endothelial growth factor (VEGF)<br>
-COX-2<br>
-capsaicin is a natural ADAM10 activator and shows potential to attenuate amyloid pathology and protect against AD<br>
<br>
<p><b>Capsaicin</b> — capsaicin is a pungent vanilloid alkaloid phytochemical from <i>Capsicum</i> peppers and the principal TRPV1 agonist responsible for chili heat. It is best classified as a natural product / small-molecule vanilloid with approved topical analgesic use but no established anticancer indication. Standard abbreviations include CAP and CAPS. In cancer literature it is a pleiotropic stressor whose dominant preclinical effects usually converge on Ca2+ influx, mitochondrial dysfunction, ROS generation, suppression of pro-survival signaling, and apoptosis, but its biology is context- and concentration-dependent, with occasional low-dose pro-migratory / pro-metastatic signaling reported.</p>
<p><b>Primary mechanisms (ranked):</b></p>
<ol>
<li>TRPV-linked cation influx with intracellular Ca2+ dysregulation, variably via TRPV1 or other TRPV-family context such as TRPV6</li>
<li>Mitochondrial injury with loss of membrane potential, cytochrome c release, and intrinsic apoptotic execution</li>
<li>Mitochondrial and cellular ROS increase with redox stress exceeding tumor buffering capacity</li>
<li>Suppression of STAT3 and related survival transcription programs in multiple models</li>
<li>Suppression of NF-κB-centered inflammatory / survival signaling, with downstream anti-migratory and radiosensitizing implications in some settings</li>
<li>PI3K/Akt/mTOR attenuation and cell-cycle restraint in responsive models</li>
<li>Contextual induction of autophagy as a stress-adaptation program that may either accompany death or partially buffer it</li>
<li>Anti-migratory / anti-invasive effects in many models, but with an important low-concentration exception in some colorectal systems</li>
</ol>
<p><b>Bioavailability / PK relevance:</b> Capsaicin is lipophilic, rapidly absorbed, and rapidly metabolized, with substantial first-pass limitation after oral exposure. Human oral PK from a capsicum preparation containing 26.6 mg capsaicin produced a Cmax of about 2.47 ng/mL at ~47 minutes, while the FDA-approved 8% topical system produced transient systemic exposure usually below 5 ng/mL, with a highest detected plasma level of 4.6 ng/mL. Delivery is therefore a major translation constraint for anticancer use, and formulation-based approaches are often invoked to overcome short half-life, irritancy, and exposure limits.</p>
<p><b>In-vitro vs systemic exposure relevance:</b> This is a major limitation. Many anticancer cell studies use roughly 10–300 µM, whereas reported human plasma exposures from oral or approved topical use are in the low ng/mL range, approximately ~0.008–0.015 µM, i.e., orders of magnitude lower than many cytotoxic in-vitro concentrations. Accordingly, direct systemic tumoricidal translation from standard dietary or approved topical exposure is weak unless local delivery, sustained-release systems, or substantially altered formulations are used.</p>
<p><b>Clinical evidence status:</b> Anticancer evidence is predominantly preclinical, with in-vitro and some in-vivo support across several tumor types. There is no regulatory approval for cancer treatment. Human oncology use is currently much more credible as supportive care for neuropathic pain, especially chemotherapy-induced peripheral neuropathy, where topical high-concentration capsaicin patches are being studied and used off-label / investigationally, rather than as a direct antitumor therapy.</p>
<h3>Mechanistic Table</h3>
<table border="1" cellspacing="0" cellpadding="4">
<tr>
<th>Rank</th>
<th>Pathway / Axis</th>
<th>Cancer Cells</th>
<th>Normal Cells</th>
<th>TSF</th>
<th>Primary Effect</th>
<th>Notes / Interpretation</th>
</tr>
<tr>
<td>1</td>
<td>TRPV-linked Ca2+ influx</td>
<td>Ca2+ ↑; death signaling ↑</td>
<td>Sensory excitation ↑; irritancy ↑</td>
<td>P/R</td>
<td>Upstream trigger</td>
<td>Usually framed through TRPV1, but some tumor models show dependence on other TRPV-family context such as TRPV6; this is mechanistically central but not uniform across cancers.</td>
</tr>
<tr>
<td>2</td>
<td>Mitochondrial membrane potential</td>
<td>MMP ↓; cytochrome c release ↑</td>
<td>↔ / stress if exposed</td>
<td>R</td>
<td>Intrinsic apoptosis initiation</td>
<td>Mitochondrial dysfunction is one of the most reproducible downstream events and often links Ca2+ overload with apoptosis.</td>
</tr>
<tr>
<td>3</td>
<td>Mitochondrial ROS increase</td>
<td>ROS ↑; redox buffering overwhelmed</td>
<td>↔ / antioxidant response may compensate</td>
<td>P/R</td>
<td>Stress amplification</td>
<td>Frequently sits upstream of mitochondrial collapse, DNA damage signaling, and apoptosis; cancer selectivity is often attributed to weaker redox reserve.</td>
</tr>
<tr>
<td>4</td>
<td>Intrinsic apoptosis machinery</td>
<td>BAX/Bak ↑; Bcl-2/Bcl-xL ↓; caspase-3/9 ↑</td>
<td>↔ / lower sensitivity in some comparisons</td>
<td>R/G</td>
<td>Execution-phase cell death</td>
<td>Common endpoint across responsive models; often follows ROS and mitochondrial injury rather than acting as the primary initiating lesion.</td>
</tr>
<tr>
<td>5</td>
<td>STAT3 survival signaling</td>
<td>STAT3 ↓</td>
<td>↔</td>
<td>R/G</td>
<td>Reduced survival and proliferation</td>
<td>Well supported in multiple myeloma and other models, but not universal; note that a HepG2 context reported ROS-associated STAT3 activation coupled to autophagy.</td>
</tr>
<tr>
<td>6</td>
<td>NF-κB inflammatory survival axis</td>
<td>NF-κB ↓</td>
<td>Inflammatory tone ↓</td>
<td>R/G</td>
<td>Anti-survival; anti-migratory</td>
<td>Important for invasion restraint and likely part of observed radiosensitization in some models.</td>
</tr>
<tr>
<td>7</td>
<td>PI3K Akt mTOR axis</td>
<td>PI3K/Akt/mTOR ↓</td>
<td>↔</td>
<td>R/G</td>
<td>Growth suppression</td>
<td>Seen in several responsive systems, but this axis is also part of the cautionary low-dose pro-metastatic literature in colorectal cancer.</td>
</tr>
<tr>
<td>8</td>
<td>Cell-cycle control</td>
<td>G0/G1 or G1/S arrest ↑</td>
<td>↔</td>
<td>G</td>
<td>Proliferation blockade</td>
<td>Usually secondary to upstream stress and survival-pathway suppression rather than the earliest event.</td>
</tr>
<tr>
<td>9</td>
<td>Autophagy stress program</td>
<td>Autophagy ↑ (context-dependent)</td>
<td>↔</td>
<td>G</td>
<td>Adaptive buffering or co-lethal stress</td>
<td>In HepG2, autophagy appeared partially protective because inhibiting it enhanced capsaicin-induced apoptosis.</td>
</tr>
<tr>
<td>10</td>
<td>Migration invasion EMT phenotype</td>
<td>Migration ↓; invasion ↓; EMT ↓ (context-dependent)</td>
<td>↔</td>
<td>G</td>
<td>Anti-metastatic phenotype</td>
<td>Frequently reported at active doses, often linked to AMPK activation and NF-κB suppression.</td>
</tr>
<tr>
<td>11</td>
<td>Low-dose paradox flag</td>
<td>ROS ↑ with Akt/mTOR ↑ and STAT3 ↑ (model-dependent)</td>
<td>↔</td>
<td>G</td>
<td>Potential pro-metastatic signaling</td>
<td>Important caution: low-concentration capsaicin has been reported to enhance metastatic behavior in colorectal cancer models.</td>
</tr>
<tr>
<td>12</td>
<td>Radiosensitization or Chemosensitization</td>
<td>Sensitivity ↑ (context-dependent)</td>
<td>Unknown</td>
<td>G</td>
<td>Adjunct potential</td>
<td>Preclinical support exists, especially via NF-κB and stress-pathway modulation, but this remains non-clinically established for direct cancer treatment.</td>
</tr>
<tr>
<td>13</td>
<td>Clinical Translation Constraint</td>
<td>Required tumoricidal exposure often not reached systemically</td>
<td>Irritation and tolerability limit escalation</td>
<td>G</td>
<td>Translation bottleneck</td>
<td>Typical antitumor in-vitro concentrations greatly exceed known plasma exposure from standard oral intake or approved topical use; formulation, local delivery, and tumor heterogeneity are major constraints.</td>
</tr>
</table>
<p>P: 0–30 min</p>
<p>R: 30 min–3 hr</p>
<p>G: >3 hr</p>